Novel CYP3A4 intron 6 single nucleotide polymorphism is associated with simvastatin-mediated cholesterol reduction in the Rotterdam Study (Q44077542)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Novel CYP3A4 intron 6 single nucleotide polymorphism is associated with simvastatin-mediated cholesterol reduction in the Rotterdam Study |
scientific article |
Statements
1 reference
Novel CYP3A4 intron 6 single nucleotide polymorphism is associated with simvastatin-mediated cholesterol reduction in the Rotterdam Study (English)
1 reference
André G Uitterlinden
1 reference
Albert Hofman
1 reference
Laure Elens
1 reference
Matthijs L Becker
1 reference
Vincent Haufroid
1 reference
Loes E Visser
1 reference
Bruno Ch Stricker
1 reference
Ron H N van Schaik
1 reference
1 December 2011
1 reference
1 reference
Identifiers
1 reference